With our partners, we are developing faster and less expensive ways of turning laboratory discoveries into new diagnostic tests and treatments for cancer and AIDS.
Nearly 700 researchers, scientists, and laboratory technicians convened in the Ronald Reagan Building and International
Trade Center in Washington, DC, for the 2014 NCI Intramural Scientific Investigators Retreat on Jan. 14.
The event featured presentations and posters exploring topics in cancer research from KRAS signaling to animal
in The Poster Online.
Aggarwal, M., T. Banerjee, et al.
Werner Syndrome Helicase Has a Critical Role in DNA Damage Responses in the Absence of a Functional Fanconi Anemia
Cancer Res 73(17):5497-5507, 2013.
Marino, N., J. C. Marshall, et al.
Nm23-H1 Binds to Gelsolin and Inactivates Its Actin-Severing Capacity to Promote Tumor Cell Motility and Metastasis.
Cancer Res 73(19):5949-5962, 2013.
Hansen, S. G., M. Piatak, et al.
Immune clearance of highly pathogenic SIV infection.
Nature 502(7469):100-104, 2013.
McShane, L. M., M. M. Cavenagh, et al.
Criteria for the use of omics-based predictors in clinical trials.
Nature 502(7471):317-320, 2013.
NCI-Frederick has about 3,000 government and contractor employees with a wide range
of expertise in basic, translational, and preclinical research and development in
cancer and AIDS.
Read about some of our recent research advances.
If you have an activity, notice or article that you feel should be featured, we
want to hear about it! Please make your request to the
NCI-Frederick Webmaster and we will do our best to post your information
in the coming months.